z-logo
open-access-imgOpen Access
Effectiveness of telemedicine use to improve patient outcome in cancer patients: A narrative review
Author(s) -
Angela Judhia Arkandhi,
Sp. Frs. apt. Woro Harjaningsih
Publication year - 2022
Publication title -
pharmacy education
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.198
H-Index - 17
eISSN - 1477-2701
pISSN - 1560-2214
DOI - 10.46542/pe.2022.222.248253
Subject(s) - telemedicine , inclusion and exclusion criteria , medicine , scopus , psychological intervention , inclusion (mineral) , health care , covid-19 , mhealth , ehealth , narrative review , the internet , pandemic , narrative , medline , medical emergency , nursing , disease , alternative medicine , world wide web , intensive care medicine , psychology , computer science , pathology , philosophy , law , economic growth , linguistics , social psychology , political science , infectious disease (medical specialty) , economics
Background: Cancer as a chronic disease requires special attention and intensive care to all aspects of treatment. Besides, in a crisis like the ongoing COVID-19 pandemic, telemedicine is beneficial for healthcare, including patient care in cancer.Objective: This review aims to explore the different types of telemedicine interventions that effectively improve patient outcomes and describe their effectiveness in improving these outcomes. Method: This study was a narrative review with articles retrieved from PubMed and Scopus databases according to inclusion and exclusion criteria.Result: A total of 26 articles was analysed in this study. The most effective form of telemedicine was mHealth, followed by web or internet-based, with the majority of activities replaced by telemedicine being monitored and followed up. Conclusion: Telemedicine is effective in improving cancer patient outcomes. This study can be considered for telemedicine implementation in Indonesia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here